MSLs in 2019: Five Things To Watch in Pharma
If you've spent a day and a half observing the pharma industry, you know things change quickly and unpredictably. No two years are created equal in the Pharma and Biotech industry. What can we look forward to for MSLs in 2019: Five Things To Watch in Pharma? 1. Mergers and Acquisitions 2019 has already been busy in the merger and acquisition department. BMS agreed to acquire Celgene last week, Eli Lilly is set to acquire Loxo Oncology this week, and the Takeda/Shire union that is imminent. With so much action in January's first week, what excitement can we expect over the next…